Rihacek, M.; Selingerova, I.; Kocak, I.; Kocakova, I.; Rihackova, E.; Valik, D.; Sterba, J.
Sunitinib-Induced Elevation of Mean Corpuscular Volume (MCV)—Exploring Its Possible Clinical Relevance in Cancer Patients. Curr. Oncol. 2022, 29, 4138-4147.
https://doi.org/10.3390/curroncol29060330
AMA Style
Rihacek M, Selingerova I, Kocak I, Kocakova I, Rihackova E, Valik D, Sterba J.
Sunitinib-Induced Elevation of Mean Corpuscular Volume (MCV)—Exploring Its Possible Clinical Relevance in Cancer Patients. Current Oncology. 2022; 29(6):4138-4147.
https://doi.org/10.3390/curroncol29060330
Chicago/Turabian Style
Rihacek, Michal, Iveta Selingerova, Ivo Kocak, Ilona Kocakova, Eva Rihackova, Dalibor Valik, and Jaroslav Sterba.
2022. "Sunitinib-Induced Elevation of Mean Corpuscular Volume (MCV)—Exploring Its Possible Clinical Relevance in Cancer Patients" Current Oncology 29, no. 6: 4138-4147.
https://doi.org/10.3390/curroncol29060330
APA Style
Rihacek, M., Selingerova, I., Kocak, I., Kocakova, I., Rihackova, E., Valik, D., & Sterba, J.
(2022). Sunitinib-Induced Elevation of Mean Corpuscular Volume (MCV)—Exploring Its Possible Clinical Relevance in Cancer Patients. Current Oncology, 29(6), 4138-4147.
https://doi.org/10.3390/curroncol29060330
